Medivation M&A

Pfizer Inc. (NYSE: PFE) confirmed Monday it has entered into an agreement to acquire Medivation Inc (NASDAQ: MDVN) for $81.50 a share. The announcement puts an end to months of speculation. Sanofi SA (ADR) (NYSE: SNY) announced in late April it sent Medivation's Board of Directors an offer...